Back
Annovis Bio, Inc. ANVS · Insights
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for... Price0.9013
Market Cap57.62 M
Float53.99 M
CountryUS
SectorHealthcare
ExchangeNYSE
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro